Somatostatin receptor subtypes in human type 2 diabetic islets

Pancreas

Volumn 39, Issue 6, 2010, Pages 836-842

  Portela Gomes, Guida M ^a   Grimelius, Lars ^b   Westermark, Per ^b   Stridsberg, Mats ^c  

^a UNIVERSITY OF LISBON   (Portugal)

^b Department of Genetics and Pathology ^*  (Australia)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

human; immunohistochemistry; pancreas; somatostatin receptors; type 2 diabetes

Indexed keywords

GLUCAGON; INSULIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

AGED; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AUTOPSY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; PANCREATIC POLYPEPTIDE-SECRETING CELLS; PROTEIN ISOFORMS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN-SECRETING CELLS;

EID: 77955180418     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181cf1878     Document Type: Article

References (23)

1. Mandarino L, Stenner D, Blanchard W, et al. Selective effects of somatostatin-14,-25 and-28 on in vitro insulin and glucagon secretion. Nature. 1981;291:76-77.
2. Kleinman R, Gingerich R, Ohning G, et al. The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas. Int J Pancreatol. 1995;18:51-57.
3. Ipp E, Rivier J, Dobbs RE, et al. Somatostatin analogs inhibit somatostatin release. Endocrinology. 1979;104:1270-1273.
4. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;3:157-198.
5. Strowski MZ, Blake AD. Function and expression of somatostatin receptors of the endocrine pancreas. Mol Cell Endocrinol. 2008;286: 169-179.
6. Portela-Gomes GM, Stridsberg M, Grimelius L, et al. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol. 2000;8:126-132.
7. Singh V, Brendel MD, Zacharias S, et al. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. J Clin Endocrinol Metab. 2007;92:673-680.
8. Westermark P, Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand A. 1973;81:291-300.
9. Heras A, Roach CM, Key ME. Enhanced polymer detection system for immunohistochemistry. Mod Pathol. 1995;8:165A.
10. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem. 1992;40: 1457-1463.
11. Portela-Gomes GM, Stridsberg M, Grimelius L, et al. Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomasVpredominance of receptor subtype 4. Endocr Pathol. 2007;18:79-85.
12. Ludvigsen E, Stridsberg M, Taylor JE, et al. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin receptor analogues. Regul Pept. 2007;138:1-9.
13. Strowski MZ, Kohler M, Chen HY, et al. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis. Mol Endocrinol. 2003;17:93-106.
14. Strowski MZ, Parmar RM, Blake AD, et al. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology. 2000;141:111-117.
15. Wang XP, Norman MA, Yang J, et al. Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice. Surgery. 2004;136:585-592.
16. Florio T. Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Front Biosci. 2008;13:822-840.
17. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-110.
18. Brunicardi FC, Chaiken RL, Ryan AS, et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab. 1996;81:3566-3572.
19. Williams G, Füessl HS, Burrin JM, et al. Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus. Horm Metab Res. 1988;20:168-170.
20. Lunetta M, Di Mauro M, Le Moli R, et al. Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients. Diabetes Res Clin Pract. 1997;38:81-89.
21. MLller LN, Stidsen CE, Hartmann B, et al. Somatostatin receptors. Biochim Biophys Acta. 2003;22(1616):1-84.
22. Slagter BJ, Kittilson J, Sheridan MA. Expression of somatostatin receptor mRNAs is regulated in vivo by growth hormone, insulin, and insulin-like growth factor-I in rainbow trout (Oncorhynchus mykiss). Regul Pept. 2005;128:27-32.
23. Nelson LE, Sheridan MA. Insulin and growth hormone stimulate somatostatin receptor (SSTR) expression by inducing transcription of SSTR mRNAs and by upregulating cell surface SSTRs. Am J Physiol Regul Integr Comp Physiol. 2006;291:R163YR169.